Zinc Metalloproteinases and Amyloid Beta-Peptide Metabolism: The Positive Side of Proteolysis in Alzheimer's Disease

Figure 2

Structures of hydroxamic acid-based zinc metalloproteinase inhibitors.

(a)

(b)

(c)

(d)